AstraZeneca
Website:
AstraZeneca
Index:
FTSE 100
EPIC: AZN
Supersector:
Health Care
Sector:
Pharmaceuticals and Biotechnology
Subsector:
Pharmaceuticals
Market Cap:
£175.6B
Payout Frequency: Semi-Annual
Next AstraZeneca Dividend
AstraZeneca next goes ex-dividend on 07/08/2025. This will be the 1st Interim dividend for 2025.
The dividend per share amount is 103.00¢ (USD) and the payment date is 08/09/2025.
AstraZeneca Annual Dividend Yield - 2.13%
Dividends Used in Calculation:
Ex-Dividend Date |
Payment Date |
Type |
Amount |
Currency |
20/02/2025 |
24/03/2025 |
2nd Interim |
210.00¢ |
USX |
07/08/2025 |
08/09/2025 |
1st Interim |
103.00¢ |
USX |
Total (Annual Dividends Per Share):
236.55p
(Using exchange rate on 31/07/2025 $1 = £0.75574)
Dividend Yield =
Annual Dividends Per Share (236.55p)
÷ Share Price (11104p)
= 2.13%
AstraZeneca Dividend History
Ex Dividend Date | Payment Date | Type | Amount | Currency |
07/08/2025 | 08/09/2025 | 1st Interim | 103.00¢ | USX |
20/02/2025 | 24/03/2025 | 2nd Interim | 210.00¢ | USX |
08/08/2024 | 09/09/2024 | 1st Interim | 100.00¢ | USX |
22/02/2024 | 25/03/2024 | 2nd Interim | 197.00¢ | USX |
10/08/2023 | 11/09/2023 | 1st Interim | 93.00¢ | USX |
23/02/2023 | 27/03/2023 | 2nd Interim | 197.00¢ | USX |
11/08/2022 | 12/09/2022 | 1st Interim | 93.00¢ | USX |
24/02/2022 | 28/03/2022 | 2nd Interim | 197.00¢ | USX |
12/08/2021 | 13/09/2021 | 1st Interim | 90.00¢ | USX |
25/02/2021 | 29/03/2021 | 2nd Interim | 190.00¢ | USX |
13/08/2020 | 14/09/2020 | 1st Interim | 90.00¢ | USX |
27/02/2020 | 30/03/2020 | 2nd Interim | 190.00¢ | USX |
08/08/2019 | 09/09/2019 | 1st Interim | 90.00¢ | USX |
08/08/2019 | 09/09/2019 | Interim | 90.00¢ | USX |
28/02/2019 | 27/03/2019 | 2nd Interim | 190.00¢ | USX |
09/08/2018 | 10/09/2018 | 1st Interim | 90.00¢ | USX |
15/02/2018 | 19/03/2018 | 2nd Interim | 190.00¢ | USX |
10/08/2017 | 11/09/2017 | 1st Interim | 90.00¢ | USX |
16/02/2017 | 20/03/2017 | 2nd Interim | 190.00¢ | USX |
11/08/2016 | 12/09/2016 | 1st Interim | 90.00¢ | USX |
17/02/2016 | 21/03/2016 | 2nd Interim | 190.00¢ | USX |
13/08/2015 | 14/09/2015 | 1st Interim | 90.00¢ | USX |
19/02/2015 | 23/03/2015 | 2nd Interim | 190.00¢ | USX |
13/08/2014 | 15/09/2014 | 1st Interim | 90.00¢ | USX |
19/02/2014 | 24/03/2014 | 2nd Interim | 190.00¢ | USX |
14/08/2013 | 16/09/2013 | 1st Interim | 90.00¢ | USX |
Year | Interim | Currency | Total | Change (%) |
2024 | | USX | 297.000 | 2.41 |
2023 | | USX | 290.000 | 0.00 |
2022 | | USX | 290.000 | 3.57 |
2021 | | USX | 280.000 | 0.00 |
2020 | | USX | 280.000 | -24.32 |
2019 | 90.000 | USX | 370.000 | 32.14 |
2018 | | USX | 280.000 | 0.00 |
2017 | | USX | 280.000 | 0.00 |
2016 | | USX | 280.000 | 0.00 |
2015 | | USX | 280.000 | 0.00 |
2014 | | USX | 280.000 | 211.11 |
2013 | | USX | 90.000 | |
AstraZeneca Dividend Calculator
AstraZeneca Dividend Growth
Dividend Growth (1Y) |
7.81%
|
Dividend CAGR (5Y) |
2.6%
|
Years of Growth |
–
|
Payout Ratio |
59.51%
|
Buyback Yield |
-0.06%
|
Shareholder Yield |
2.03%
|
AstraZeneca Valuation & Profitability
P/E Ratio (TTM) |
29.23
|
Forward P/E |
15.42
|
P/FCF |
21.53
|
Earnings Yield |
3.45%
|
FCF Yield |
4.65%
|
ROE |
19.67%
|
ROCE |
18.19%
|
Profit Margin |
14.68%
|
Operating Margin |
25.4%
|
Gross Margin |
82.26%
|